ArticleRole of CD319 Expression as A Diagnostic and Prognostic Marker in Plasma Cell Myeloma Patients
ArticleRole of CD319 Expression as A Diagnostic and Prognostic Marker in Plasma Cell Myeloma Patients
ArticleInterleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma
ArticleInterleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma
ArticlePROGNOSTIC IMPLICATIONS OF ENDOTHELIAL ACTIVATION AND STRESS INDEX (EASIX) IN MULTIPLE MYELOMA PATIENTS
ArticlePROGNOSTIC IMPLICATIONS OF ENDOTHELIAL ACTIVATION AND STRESS INDEX (EASIX) IN MULTIPLE MYELOMA PATIENTS
ArticlePrognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia
ArticlePrognostic Relevance of CD69, Vascular Endothelial Growth Factor and Thymidine Kinase in B-Chronic Lymphocytic Leukemia
ArticleEvaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia
ArticleEvaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia